Cell Therapy – Medical Alley Association

Cell Therapy

LEAH Labs Awarded NIH Phase I SBIR Grant

“A non-viral gene editing platform for cell therapies and translational autoimmune disease modeling” MEDICAL ALLEY, Minnesota (March 1st, 2022) — LEAH Labs, a Y Combinator-backed companion animal biotechnology company building a better future for pets and their humans, has been awarded a $337,443 National Institute of Health (NIH) Phase I Small Business Innovation Research grant […]

For the Record With Kevin Ballinger, CEO, Aldevron

Kevin Ballinger brings to Aldevron over 25 years of product development, operations, commercial and general management leadership in the medical device industry. Prior to joining Aldevron in July 2020, Kevin worked for Boston Scientific where he served nine years as Executive Vice President and Global President of their largest division, Interventional Cardiology (IC). As one […]

Aldevron to Build 14-Acre Gene Therapy Manufacturing Campus

August ground breaking of second GMP manufacturing facility Expands GMP and GMP SourceTM plasmid capacity 10-fold Supports gene editing, gene therapy, and cell therapy applications Includes synthetic production of nucleic acids, vertical integration for clients FARGO, N.D. (June 3, 2019) – Aldevron, a leader in the production of plasmid DNA, proteins, mRNA and antibodies; announced […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER